Header Logo

Connection

Barry Maron to Male

Back to Details
This is a "connection" page, showing publications Barry Maron has written about Male.
Barry Maron
Connection Strength
4.578
Male
  1. Harris KM, Mackey-Bojack S, Fisher G, Nwaudo D, Maron BJ. Arrhythmogenic Mitral Valve Prolapse Revisited: A Not Uncommon Cause of Youthful Sudden Death in Athletes and Women. Am J Med. 2025 Jan; 138(1):156-160.
    View in: PubMed
    Score: 0.056
  2. Bonaventura J, Rowin EJ, Maron MS, Maron BJ. Risks of the Athletic Field Revisited: Report of Unusual Occurrences of Cardiac Arrest and Sudden Death in Professional Soccer Players. Am J Med. 2023 03; 136(3):315-321.
    View in: PubMed
    Score: 0.050
  3. Maron BA, Kleiner DE, Arons E, Wertheim BM, Sharma NS, Haley KJ, Samokhin AO, Rowin EJ, Maron MS, Rosing DR, Maron BJ. Evidence of Advanced Pulmonary Vascular Remodeling in Obstructive Hypertrophic Cardiomyopathy With Pulmonary Hypertension. Chest. 2023 03; 163(3):678-686.
    View in: PubMed
    Score: 0.049
  4. Harris KM, Mackey-Bojack S, Bennett M, Nwaudo D, Duncanson E, Maron BJ. Sudden Unexpected Death Due to Myocarditis in Young People, Including Athletes. Am J Cardiol. 2021 03 15; 143:131-134.
    View in: PubMed
    Score: 0.044
  5. Shirani J, Aurshiya R, Elshaikh A, Olenchock SA, Rowin EJ, Maron MS, Maron BJ. Low Risk of Hypertrophic Cardiomyopathy With Contemporary Management Strategies Implemented in Non-Referral Regional Community-Based Practices. Am J Cardiol. 2021 03 01; 142:130-135.
    View in: PubMed
    Score: 0.043
  6. Rowin EJ, Burrows A, Madias C, Estes NAM, Link MS, Maron MS, Maron BJ. Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator Implants. Circ Arrhythm Electrophysiol. 2020 10; 13(10):e008123.
    View in: PubMed
    Score: 0.043
  7. Rowin EJ, Sridharan A, Madias C, Firely C, Koethe B, Link MS, Maron MS, Maron BJ. Prediction and Prevention of Sudden Death in Young Patients (<20 years) With Hypertrophic Cardiomyopathy. Am J Cardiol. 2020 08 01; 128:75-83.
    View in: PubMed
    Score: 0.042
  8. Maron BJ, Rowin EJ, Arkun K, Rastegar H, Larson AM, Maron MS, Chin MT. Adult Monozygotic Twins With Hypertrophic Cardiomyopathy and Identical Disease Expression and Clinical Course. Am J Cardiol. 2020 07 15; 127:135-138.
    View in: PubMed
    Score: 0.042
  9. Rowin EJ, Maron MS, Bhatt V, Gillam L, Maron BJ. Hypertrophic Cardiomyopathy in "Real-World" Community Cardiology Practice. Am J Cardiol. 2020 05 01; 125(9):1398-1403.
    View in: PubMed
    Score: 0.041
  10. Sharkey SW, Kalra A, Henry TD, Smith TD, Pink VR, Lesser JR, Garberich RF, Maron MS, Maron BJ. Coexistence of acute takotsubo syndrome and acute coronary syndrome. Catheter Cardiovasc Interv. 2020 10 01; 96(4):825-829.
    View in: PubMed
    Score: 0.040
  11. Rowin EJ, Maron MS, Wells S, Patel PP, Koethe BC, Maron BJ. Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy. J Am Heart Assoc. 2019 11 05; 8(21):e012041.
    View in: PubMed
    Score: 0.040
  12. Maron BJ, Harris KM, Maron MS. The Guidant Affair revisited?but this time with good news. Heart Rhythm. 2020 03; 17(3):512-513.
    View in: PubMed
    Score: 0.040
  13. Maron MS, Rowin EJ, Wessler BS, Mooney PJ, Fatima A, Patel P, Koethe BC, Romashko M, Link MS, Maron BJ. Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy. JAMA Cardiol. 2019 07 01; 4(7):644-657.
    View in: PubMed
    Score: 0.039
  14. Maron BJ, Maron MS, Maron BA, Loscalzo J. Moving Beyond the Sarcomere to Explain?Heterogeneity in Hypertrophic?Cardiomyopathy: JACC Review Topic of the Week. J Am Coll Cardiol. 2019 04 23; 73(15):1978-1986.
    View in: PubMed
    Score: 0.039
  15. Maurizi N, Michels M, Rowin EJ, Semsarian C, Girolami F, Tomberli B, Cecchi F, Maron MS, Olivotto I, Maron BJ. Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy. Circulation. 2019 02 05; 139(6):830-833.
    View in: PubMed
    Score: 0.038
  16. Maron BJ, Thompson PD. Longevity in elite athletes: the first 4-min milers. Lancet. 2018 09 15; 392(10151):913.
    View in: PubMed
    Score: 0.037
  17. Maron BJ. Clinical Course and Management of Hypertrophic Cardiomyopathy. N Engl J Med. 2018 Aug 16; 379(7):655-668.
    View in: PubMed
    Score: 0.037
  18. Wells S, Rowin EJ, Bhatt V, Maron MS, Maron BJ. Association Between Race and Clinical Profile of Patients Referred for Hypertrophic Cardiomyopathy. Circulation. 2018 05 01; 137(18):1973-1975.
    View in: PubMed
    Score: 0.036
  19. Maron BJ, Casey SA, Olivotto I, Sherrid MV, Semsarian C, Autore C, Ahmed A, Boriani G, Francia P, Winters SL, Giudici M, Koulova A, Garberich R, Rowin EJ, Sears SF, Maron MS, Spirito P. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators. Circ Arrhythm Electrophysiol. 2018 04; 11(4):e005820.
    View in: PubMed
    Score: 0.036
  20. Wells S, Rowin EJ, Boll G, Rastegar H, Wang W, Maron MS, Maron BJ. Clinical Profile of Nonresponders to Surgical Myectomy with Obstructive Hypertrophic Cardiomyopathy. Am J Med. 2018 06; 131(6):e235-e239.
    View in: PubMed
    Score: 0.036
  21. Maron MS, Xin W, Sims KB, Butler R, Haas TS, Rowin EJ, Desnick RJ, Maron BJ. Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy. Am J Med. 2018 02; 131(2):200.e1-200.e8.
    View in: PubMed
    Score: 0.035
  22. Rowin EJ, Maron MS, Chan RH, Hausvater A, Wang W, Rastegar H, Maron BJ. Interaction of Adverse Disease Related Pathways in Hypertrophic Cardiomyopathy. Am J Cardiol. 2017 Dec 15; 120(12):2256-2264.
    View in: PubMed
    Score: 0.035
  23. Harris KM, Creswell LL, Haas TS, Thomas T, Tung M, Isaacson E, Garberich RF, Maron BJ. Death and Cardiac Arrest in U.S. Triathlon Participants, 1985 to 2016: A Case Series. Ann Intern Med. 2017 Oct 17; 167(8):529-535.
    View in: PubMed
    Score: 0.035
  24. Rowin EJ, Hausvater A, Link MS, Abt P, Gionfriddo W, Wang W, Rastegar H, Estes NAM, Maron MS, Maron BJ. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy. Circulation. 2017 Dec 19; 136(25):2420-2436.
    View in: PubMed
    Score: 0.035
  25. Maron MS, Rowin EJ, Maron BJ. How to Image Hypertrophic Cardiomyopathy. Circ Cardiovasc Imaging. 2017 07; 10(7).
    View in: PubMed
    Score: 0.034
  26. Link MS, Bockstall K, Weinstock J, Alsheikh-Ali AA, Semsarian C, Estes NAM, Spirito P, Haas TS, Rowin EJ, Maron MS, Maron BJ. Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications. J Cardiovasc Electrophysiol. 2017 May; 28(5):531-537.
    View in: PubMed
    Score: 0.034
  27. Rowin EJ, Orfanos A, Estes NAM, Wang W, Link MS, Maron MS, Maron BJ. Occurrence and Natural History of Clinically Silent Episodes of Atrial Fibrillation in Hypertrophic Cardiomyopathy. Am J Cardiol. 2017 06 01; 119(11):1862-1865.
    View in: PubMed
    Score: 0.034
  28. Sorajja P, Pedersen WA, Bae R, Lesser JR, Jay D, Lin D, Harris K, Maron BJ. First Experience With Percutaneous?Mitral?Valve Plication as Primary Therapy?for Symptomatic Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2016 06 21; 67(24):2811-8.
    View in: PubMed
    Score: 0.032
  29. Maron BJ, Haas TS, Ahluwalia A, Murphy CJ, Garberich RF. Demographics and Epidemiology of Sudden Deaths in Young Competitive Athletes: From the United States National Registry. Am J Med. 2016 Nov; 129(11):1170-1177.
    View in: PubMed
    Score: 0.031
  30. Maron MS, Rowin EJ, Olivotto I, Casey SA, Arretini A, Tomberli B, Garberich RF, Link MS, Chan RHM, Lesser JR, Maron BJ. Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2016 Mar 29; 67(12):1399-1409.
    View in: PubMed
    Score: 0.031
  31. Kalra A, Harris KM, Maron BA, Maron MS, Garberich RF, Haas TS, Lesser JR, Maron BJ. Relation of Doppler Tissue Imaging Parameters With Heart Failure Progression in Hypertrophic Cardiomyopathy. Am J Cardiol. 2016 06 01; 117(11):1808-14.
    View in: PubMed
    Score: 0.031
  32. Maron MS, Maron BJ. Response to Letter Regarding Article, "Clinical Impact of Contemporary Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy". Circulation. 2016 Mar 01; 133(9):e422.
    View in: PubMed
    Score: 0.031
  33. Maron BJ, Maron MS. Nonobstructive Hypertrophic Cardiomyopathy: Overlooked But Not Forgotten. Mayo Clin Proc. 2016 Mar; 91(3):277-8.
    View in: PubMed
    Score: 0.031
  34. Maron BJ, Haas TS, Duncanson ER, Garberich RF, Baker AM, Mackey-Bojack S. Comparison of the Frequency of Sudden Cardiovascular Deaths in Young Competitive Athletes Versus Nonathletes: Should We Really Screen Only Athletes? Am J Cardiol. 2016 Apr 15; 117(8):1339-41.
    View in: PubMed
    Score: 0.031
  35. Maron BJ, Zipes DP, Kovacs RJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2343-2349.
    View in: PubMed
    Score: 0.030
  36. Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NAM, Cooper LT, Link MS, Maron MS. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2362-2371.
    View in: PubMed
    Score: 0.030
  37. Maron BJ, Levine BD, Washington RL, Baggish AL, Kovacs RJ, Maron MS. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2356-2361.
    View in: PubMed
    Score: 0.030
  38. Ackerman MJ, Zipes DP, Kovacs RJ, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2424-2428.
    View in: PubMed
    Score: 0.030
  39. Braverman AC, Harris KM, Kovacs RJ, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2398-2405.
    View in: PubMed
    Score: 0.030
  40. Maron BJ, Harris KM, Thompson PD, Eichner ER, Steinberg MH. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2444-2446.
    View in: PubMed
    Score: 0.030
  41. Link MS, Estes NAM, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2439-2443.
    View in: PubMed
    Score: 0.030
  42. Maron BJ, Rowin EJ, Casey SA, Lesser JR, Garberich RF, McGriff DM, Maron MS. Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies. Circulation. 2016 Jan 05; 133(1):62-73.
    View in: PubMed
    Score: 0.030
  43. Semsarian C, Ingles J, Maron MS, Maron BJ. Reply: What Is the True Prevalence of Hypertrophic Cardiomyopathy? J Am Coll Cardiol. 2015 Oct 20; 66(16):1846-1847.
    View in: PubMed
    Score: 0.030
  44. Maron BJ, Dearani JA, Ommen SR, Maron MS, Schaff HV, Nishimura RA, Ralph-Edwards A, Rakowski H, Sherrid MV, Swistel DG, Balaram S, Rastegar H, Rowin EJ, Smedira NG, Lytle BW, Desai MY, Lever HM. Low Operative Mortality Achieved With Surgical Septal Myectomy: Role of Dedicated Hypertrophic Cardiomyopathy Centers in the Management of Dynamic Subaortic Obstruction. J Am Coll Cardiol. 2015 Sep 15; 66(11):1307-1308.
    View in: PubMed
    Score: 0.030
  45. Maron MS, Maron BJ. Clinical Impact of Contemporary Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy. Circulation. 2015 Jul 28; 132(4):292-8.
    View in: PubMed
    Score: 0.030
  46. Sharkey SW, Pink VR, Lesser JR, Garberich RF, Maron MS, Maron BJ. Clinical Profile of Patients With High-Risk Tako-Tsubo Cardiomyopathy. Am J Cardiol. 2015 Sep 01; 116(5):765-72.
    View in: PubMed
    Score: 0.030
  47. Maron BJ, Casey SA, Chan RH, Garberich RF, Rowin EJ, Maron MS. Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy. Am J Cardiol. 2015 Sep 01; 116(5):757-64.
    View in: PubMed
    Score: 0.030
  48. Maron BJ, Rowin EJ, Kalra A, Lesser JR, Maron MS. Reply: To PMID 25759101. Am J Cardiol. 2015 Aug 01; 116(3):492-3.
    View in: PubMed
    Score: 0.030
  49. Maron BJ, Rowin EJ, Casey SA, Link MS, Lesser JR, Chan RH, Garberich RF, Udelson JE, Maron MS. Hypertrophic Cardiomyopathy in?Adulthood Associated With Low?Cardiovascular Mortality With Contemporary Management Strategies. J Am Coll Cardiol. 2015 May 12; 65(18):1915-28.
    View in: PubMed
    Score: 0.030
  50. Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2015 Mar 31; 65(12):1249-1254.
    View in: PubMed
    Score: 0.029
  51. Sharkey SW, McAllister N, Dassenko D, Lin D, Han K, Maron BJ. Evidence That High Catecholamine Levels Produced by Pheochromocytoma May be Responsible for Tako-Tsubo Cardiomyopathy. Am J Cardiol. 2015 Jun 01; 115(11):1615-8.
    View in: PubMed
    Score: 0.029
  52. Kalra A, Maron MS, Rowin EJ, Colgan TK, Lesser JR, Maron BJ. Coronary embolization in hypertrophic cardiomyopathy with left ventricular apical aneurysm. Am J Cardiol. 2015 May 01; 115(9):1318-9.
    View in: PubMed
    Score: 0.029
  53. Sharkey SW, Maron BJ. Left ventricular end diastolic pressure, suspected underlying hypertrophic cardiomyopathy, and takotsubo syndrome ? reply. Circ J. 2015; 79(1):222.
    View in: PubMed
    Score: 0.029
  54. Maron BJ, Nishimura RA. Revisiting arrhythmic risk after alcohol septal ablation: is the pendulum finally swinging?back to myectomy? JACC Heart Fail. 2014 Dec; 2(6):637-40.
    View in: PubMed
    Score: 0.028
  55. Maron BJ, Friedman RA, Kligfield P, Levine BD, Viskin S, Chaitman BR, Okin PM, Saul JP, Salberg L, Van Hare GF, Soliman EZ, Chen J, Matherne GP, Bolling SF, Mitten MJ, Caplan A, Balady GJ, Thompson PD. Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol. 2014 Oct 07; 64(14):1479-514.
    View in: PubMed
    Score: 0.028
  56. Maron BJ, Friedman R. To the editor--Participation screening for athletes. Heart Rhythm. 2014 Dec; 11(12):e199-200.
    View in: PubMed
    Score: 0.028
  57. Sharkey SW, Maron BJ. Epidemiology and clinical profile of Takotsubo cardiomyopathy. Circ J. 2014; 78(9):2119-28.
    View in: PubMed
    Score: 0.028
  58. Quattrini FM, Pelliccia A, Assorgi R, DiPaolo FM, Squeo MR, Culasso F, Castelli V, Link MS, Maron BJ. Benign clinical significance of J-wave pattern (early repolarization) in highly trained athletes. Heart Rhythm. 2014 Nov; 11(11):1974-82.
    View in: PubMed
    Score: 0.028
  59. Maron BJ, Maron MS. The 25-year genetic era in hypertrophic cardiomyopathy: revisited. Circ Cardiovasc Genet. 2014 Aug; 7(4):401-4.
    View in: PubMed
    Score: 0.028
  60. Spirito P, Autore C, Maron BJ. Reply: To PMID 24630786. Am J Cardiol. 2014 Aug 01; 114(3):501.
    View in: PubMed
    Score: 0.028
  61. Maron BJ, Haas TS, Goodman JS. Hypertrophic cardiomyopathy: one gene ? but many phenotypes. Am J Cardiol. 2014 May 15; 113(10):1772-3.
    View in: PubMed
    Score: 0.027
  62. Maron BJ, Haas TS, Murphy CJ, Ahluwalia A, Rutten-Ramos S. Incidence and causes of sudden death in U.S. college athletes. J Am Coll Cardiol. 2014 Apr 29; 63(16):1636-43.
    View in: PubMed
    Score: 0.027
  63. Maron BJ, Murphy CJ, Haas TS, Ahluwalia A, Garberich RF. Strategies for assessing the prevalence of cardiovascular sudden deaths in young competitive athletes. Int J Cardiol. 2014 May 15; 173(3):369-72.
    View in: PubMed
    Score: 0.027
  64. Spirito P, Autore C, Formisano F, Assenza GE, Biagini E, Haas TS, Bongioanni S, Semsarian C, Devoto E, Musumeci B, Lai F, Yeates L, Conte MR, Rapezzi C, Boni L, Maron BJ. Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors. Am J Cardiol. 2014 May 01; 113(9):1550-5.
    View in: PubMed
    Score: 0.027
  65. Maron BJ, Haas TS, Maron MS, Lesser JR, Browning JA, Chan RH, Olivotto I, Garberich RF, Schwartz RS. Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance. Am J Cardiol. 2014 Apr 15; 113(8):1394-400.
    View in: PubMed
    Score: 0.027
  66. Fox PR, Basso C, Thiene G, Maron BJ. Spontaneously occurring restrictive nonhypertrophied cardiomyopathy in domestic cats: a new animal model of human disease. Cardiovasc Pathol. 2014 Jan-Feb; 23(1):28-34.
    View in: PubMed
    Score: 0.026
  67. Maron BJ, Spirito P, Ackerman MJ, Casey SA, Semsarian C, Estes NA, Shannon KM, Ashley EA, Day SM, Pacileo G, Formisano F, Devoto E, Anastasakis A, Bos JM, Woo A, Autore C, Pass RH, Boriani G, Garberich RF, Almquist AK, Russell MW, Boni L, Berger S, Maron MS, Link MS. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2013 Apr 09; 61(14):1527-35.
    View in: PubMed
    Score: 0.026
  68. Maron BJ, Maron MS. Hypertrophic cardiomyopathy in childhood: the gradient is not the disease. Excessive use of experimental invasive interventions. J Am Coll Cardiol. 2013 Jan 15; 61(2):210-1.
    View in: PubMed
    Score: 0.025
  69. Maron BJ, Harris KM, Haas TS, Eichner ER. Reply: To PMID 22809753. Am J Cardiol. 2013 Jan 01; 111(1):149.
    View in: PubMed
    Score: 0.025
  70. Maron BJ, Rowin EJ, Casey SA, Haas TS, Chan RH, Udelson JE, Garberich RF, Lesser JR, Appelbaum E, Manning WJ, Maron MS. Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age. Circulation. 2013 Feb 05; 127(5):585-93.
    View in: PubMed
    Score: 0.025
  71. Maron BJ, Haas TS, Ahluwalia A, Rutten-Ramos SC. Incidence of cardiovascular sudden deaths in Minnesota high school athletes. Heart Rhythm. 2013 Mar; 10(3):374-7.
    View in: PubMed
    Score: 0.025
  72. Maron BJ, Haas TS, Ahluwalia A, Garberich RF, Estes NA, Link MS. Increasing survival rate from commotio cordis. Heart Rhythm. 2013 Feb; 10(2):219-23.
    View in: PubMed
    Score: 0.025
  73. Alsheikh-Ali AA, Link MS, Semsarian C, Shen WK, Estes NA, Maron MS, Haas TS, Formisano F, Boriani G, Spirito P, Maron BJ. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients. Heart Rhythm. 2013 Feb; 10(2):214-8.
    View in: PubMed
    Score: 0.025
  74. Maron BJ, Braunwald E. Evolution of hypertrophic cardiomyopathy to a contemporary treatable disease. Circulation. 2012 Sep 25; 126(13):1640-4.
    View in: PubMed
    Score: 0.025
  75. Harris KM, Haas TS, Eichner ER, Maron BJ. Sickle cell trait associated with sudden death in competitive athletes. Am J Cardiol. 2012 Oct 15; 110(8):1185-8.
    View in: PubMed
    Score: 0.024
  76. Sharkey SW, Lesser JR, Garberich RF, Pink VR, Maron MS, Maron BJ. Comparison of circadian rhythm patterns in Tako-tsubo cardiomyopathy versus ST-segment elevation myocardial infarction. Am J Cardiol. 2012 Sep 15; 110(6):795-9.
    View in: PubMed
    Score: 0.024
  77. Nistri S, Olivotto I, Maron MS, Ferrantini C, Coppini R, Grifoni C, Baldini K, Sgalambro A, Cecchi F, Maron BJ. ? Blockers for prevention of exercise-induced left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2012 Sep 01; 110(5):715-9.
    View in: PubMed
    Score: 0.024
  78. Maron MS, Rowin EJ, Lin D, Appelbaum E, Chan RH, Gibson CM, Lesser JR, Lindberg J, Haas TS, Udelson JE, Manning WJ, Maron BJ. Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. 2012 Jul; 5(4):441-7.
    View in: PubMed
    Score: 0.024
  79. Pelliccia A, Maron MS, Maron BJ. Assessment of left ventricular hypertrophy in a trained athlete: differential diagnosis of physiologic athlete's heart from pathologic hypertrophy. Prog Cardiovasc Dis. 2012 Mar-Apr; 54(5):387-96.
    View in: PubMed
    Score: 0.024
  80. Maron BJ, Casey SA, Haas TS, Kitner CL, Garberich RF, Lesser JR. Hypertrophic cardiomyopathy with longevity to 90 years or older. Am J Cardiol. 2012 May 01; 109(9):1341-7.
    View in: PubMed
    Score: 0.024
  81. Maron BJ, Semsarian C. Prevention of sudden death for patients with cardiomyopathies another step forward. J Am Coll Cardiol. 2012 Jan 31; 59(5):501-2.
    View in: PubMed
    Score: 0.024
  82. Rowin EJ, Maron MS, Lesser JR, Maron BJ. CMR with late gadolinium enhancement in genotype positive-phenotype negative hypertrophic cardiomyopathy. JACC Cardiovasc Imaging. 2012 Jan; 5(1):119-22.
    View in: PubMed
    Score: 0.023
  83. Maron BJ, Haas TS, Kitner C, Lesser JR. Onset of apical hypertrophic cardiomyopathy in adulthood. Am J Cardiol. 2011 Dec 15; 108(12):1783-7.
    View in: PubMed
    Score: 0.023
  84. Maron BJ, Maron MS, Semsarian C. Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a potential link to sudden death in the absence of conventional risk factors. Heart Rhythm. 2012 Jan; 9(1):57-63.
    View in: PubMed
    Score: 0.023
  85. Maron BJ, Ahluwalia A, Haas TS, Semsarian C, Link MS, Estes NA. Global epidemiology and demographics of commotio cordis. Heart Rhythm. 2011 Dec; 8(12):1969-71.
    View in: PubMed
    Score: 0.023
  86. Thomas M, Haas TS, Doerer JJ, Hodges JS, Aicher BO, Garberich RF, Mueller FO, Cantu RC, Maron BJ. Epidemiology of sudden death in young, competitive athletes due to blunt trauma. Pediatrics. 2011 Jul; 128(1):e1-8.
    View in: PubMed
    Score: 0.023
  87. Maron BJ, Maron MS, Maron BA, Haas TS, Altman RK, Smalley SJ, Doerer JJ, Link MS, Mooney MR. Successful therapeutic hypothermia in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2011 Jun 14; 57(24):2454-6.
    View in: PubMed
    Score: 0.023
  88. Maron MS, Olivotto I, Harrigan C, Appelbaum E, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron BJ. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy. Circulation. 2011 Jul 05; 124(1):40-7.
    View in: PubMed
    Score: 0.022
  89. Maron BJ, Lindberg J, Haas TS, Kitner C, Schum K, Lesser JR, Maron MS. "Speckled" ventricular septum in hypertrophic cardiomyopathy revisited after 30 years. Am J Cardiol. 2011 Jun 15; 107(12):1862-3.
    View in: PubMed
    Score: 0.022
  90. Lin D, Lesser JR, Maron BJ. Coexistence of late gadolinium enhancement due to myocardial infarction and hypertrophic cardiomyopathy. Heart. 2011 May; 97(10):861-2.
    View in: PubMed
    Score: 0.022
  91. Chung WK, Kitner C, Maron BJ. Novel frameshift mutation in Troponin C ( TNNC1) associated with hypertrophic cardiomyopathy and sudden death. Cardiol Young. 2011 Jun; 21(3):345-8.
    View in: PubMed
    Score: 0.022
  92. Nistri S, Olivotto I, Maron MS, Grifoni C, Baldini K, Baldi M, Sgalambro A, Cecchi F, Maron BJ. Timing and significance of exercise-induced left ventricular outflow tract pressure gradients in hypertrophic cardiomyopathy. Am J Cardiol. 2010 Nov 01; 106(9):1301-6.
    View in: PubMed
    Score: 0.021
  93. Pelliccia A, Di Paolo FM, De Blasiis E, Quattrini FM, Pisicchio C, Guerra E, Culasso F, Maron BJ. Prevalence and clinical significance of aortic root dilation in highly trained competitive athletes. Circulation. 2010 Aug 17; 122(7):698-706, 3 p following 706.
    View in: PubMed
    Score: 0.021
  94. Maron MS, Lesser JR, Maron BJ. Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance. Am J Cardiol. 2010 Jun 15; 105(12):1842-3.
    View in: PubMed
    Score: 0.021
  95. Melacini P, Basso C, Angelini A, Calore C, Bobbo F, Tokajuk B, Bellini N, Smaniotto G, Zucchetto M, Iliceto S, Thiene G, Maron BJ. Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy. Eur Heart J. 2010 Sep; 31(17):2111-23.
    View in: PubMed
    Score: 0.021
  96. Pelliccia A, Kinoshita N, Pisicchio C, Quattrini F, Dipaolo FM, Ciardo R, Di Giacinto B, Guerra E, De Blasiis E, Casasco M, Culasso F, Maron BJ. Long-term clinical consequences of intense, uninterrupted endurance training in olympic athletes. J Am Coll Cardiol. 2010 Apr 13; 55(15):1619-25.
    View in: PubMed
    Score: 0.021
  97. Harris KM, Henry JT, Rohman E, Haas TS, Maron BJ. Sudden death during the triathlon. JAMA. 2010 Apr 07; 303(13):1255-7.
    View in: PubMed
    Score: 0.021
  98. Maron BJ, Estes NA. Commotio cordis. N Engl J Med. 2010 Mar 11; 362(10):917-27.
    View in: PubMed
    Score: 0.021
  99. Sharkey SW, Windenburg DC, Lesser JR, Maron MS, Hauser RG, Lesser JN, Haas TS, Hodges JS, Maron BJ. Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol. 2010 Jan 26; 55(4):333-41.
    View in: PubMed
    Score: 0.020
  100. Maron BJ. Dr. Gunnar Thor Gunnarsson and hypertrophic cardiomyopathy: what "giving back" means. Am J Cardiol. 2010 Jan 15; 105(2):277-8.
    View in: PubMed
    Score: 0.020
  101. Sherrid MV, Cotiga D, Hart D, Ehlert F, Haas TS, Shen WK, Link MS, Estes NA, Epstein AE, Semsarian C, Daubert JP, Winters SL, Giudici MC, Maron BJ. Relation of 12-lead electrocardiogram patterns to implanted defibrillator-terminated ventricular tachyarrhythmias in hypertrophic cardiomyopathy. Am J Cardiol. 2009 Dec 15; 104(12):1722-6.
    View in: PubMed
    Score: 0.020
  102. Maron BJ, Lesser JR, Schiller NB, Harris KM, Brown C, Rehm HL. Implications of hypertrophic cardiomyopathy transmitted by sperm donation. JAMA. 2009 Oct 21; 302(15):1681-4.
    View in: PubMed
    Score: 0.020
  103. Knickelbine T, Lesser JR, Haas TS, Brandenburg ER, Gleason-Han BK, Flygenring B, Longe TF, Schwartz RS, Maron BJ. Identification of unexpected nonatherosclerotic cardiovascular disease with coronary CT angiography. JACC Cardiovasc Imaging. 2009 Sep; 2(9):1085-92.
    View in: PubMed
    Score: 0.020
  104. Maron BJ, Doerer JJ, Haas TS, Estes NA, Hodges JS, Link MS. Commotio cordis and the epidemiology of sudden death in competitive lacrosse. Pediatrics. 2009 Sep; 124(3):966-71.
    View in: PubMed
    Score: 0.020
  105. Basso C, Thiene G, Mackey-Bojack S, Frigo AC, Corrado D, Maron BJ. Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death. Eur Heart J. 2009 Jul; 30(13):1627-34.
    View in: PubMed
    Score: 0.019
  106. Maron BJ, Roberts WC, Arad M, Haas TS, Spirito P, Wright GB, Almquist AK, Baffa JM, Saul JP, Ho CY, Seidman J, Seidman CE. Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. JAMA. 2009 Mar 25; 301(12):1253-9.
    View in: PubMed
    Score: 0.019
  107. Spirito P, Autore C, Rapezzi C, Bernab? P, Badagliacca R, Maron MS, Bongioanni S, Coccolo F, Estes NA, Barill? CS, Biagini E, Quarta G, Conte MR, Bruzzi P, Maron BJ. Syncope and risk of sudden death in hypertrophic cardiomyopathy. Circulation. 2009 Apr 07; 119(13):1703-10.
    View in: PubMed
    Score: 0.019
  108. Maron BJ, Haas TS, Shannon KM, Almquist AK, Hodges JS. Long-term survival after cardiac arrest in hypertrophic cardiomyopathy. Heart Rhythm. 2009 Jul; 6(7):993-7.
    View in: PubMed
    Score: 0.019
  109. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009 Mar 03; 119(8):1085-92.
    View in: PubMed
    Score: 0.019
  110. Maron BJ, Semsarian C, Shen WK, Link MS, Epstein AE, Estes NA, Almquist A, Giudici MC, Haas TS, Hodges JS, Spirito P. Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy. Heart Rhythm. 2009 May; 6(5):599-602.
    View in: PubMed
    Score: 0.019
  111. Maron BJ, Bonow RO, Salberg L, Roberts WC, Braunwald E. The first patient clinically diagnosed with hypertrophic cardiomyopathy. Am J Cardiol. 2008 Nov 15; 102(10):1418-20.
    View in: PubMed
    Score: 0.019
  112. Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, Lesser JR, Udelson JE, Ackerman MJ, Maron BJ. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation. 2008 Oct 07; 118(15):1541-9.
    View in: PubMed
    Score: 0.019
  113. Olivotto I, Maron MS, Autore C, Lesser JR, Rega L, Casolo G, De Santis M, Quarta G, Nistri S, Cecchi F, Salton CJ, Udelson JE, Manning WJ, Maron BJ. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008 Aug 12; 52(7):559-66.
    View in: PubMed
    Score: 0.018
  114. Link MS, Bir C, Dau N, Madias C, Estes NA, Maron BJ. Protecting our children from the consequences of chest blows on the playing field: a time for science over marketing. Pediatrics. 2008 Aug; 122(2):437-9.
    View in: PubMed
    Score: 0.018
  115. Maron MS, Appelbaum E, Harrigan CJ, Buros J, Gibson CM, Hanna C, Lesser JR, Udelson JE, Manning WJ, Maron BJ. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail. 2008 Sep; 1(3):184-91.
    View in: PubMed
    Score: 0.018
  116. Pelliccia A, Di Paolo FM, Quattrini FM, Basso C, Culasso F, Popoli G, De Luca R, Spataro A, Biffi A, Thiene G, Maron BJ. Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med. 2008 Jan 10; 358(2):152-61.
    View in: PubMed
    Score: 0.018
  117. Maron BJ, Maron MS, Lesser JR, Hauser RG, Haas TS, Harrigan CJ, Appelbaum E, Main ML, Roberts WC. Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status. Am J Cardiol. 2008 Feb 15; 101(4):544-7.
    View in: PubMed
    Score: 0.018
  118. Glover DW, Glover DW, Maron BJ. Evolution in the process of screening United States high school student-athletes for cardiovascular disease. Am J Cardiol. 2007 Dec 01; 100(11):1709-12.
    View in: PubMed
    Score: 0.017
  119. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NA, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA. 2007 Jul 25; 298(4):405-12.
    View in: PubMed
    Score: 0.017
  120. Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, Cohen D, Dimeff R, Douglas PS, Glover DW, Hutter AM, Krauss MD, Maron MS, Mitten MJ, Roberts WO, Puffer JC. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2007 Mar 27; 115(12):1643-455.
    View in: PubMed
    Score: 0.017
  121. Doerer JJ, Haas TS, Estes NA, Link MS, Maron BJ. Evaluation of chest barriers for protection against sudden death due to commotio cordis. Am J Cardiol. 2007 Mar 15; 99(6):857-9.
    View in: PubMed
    Score: 0.017
  122. Valeti US, Nishimura RA, Holmes DR, Araoz PA, Glockner JF, Breen JF, Ommen SR, Gersh BJ, Tajik AJ, Rihal CS, Schaff HV, Maron BJ. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2007 Jan 23; 49(3):350-7.
    View in: PubMed
    Score: 0.017
  123. Drezner JA, Courson RW, Roberts WO, Mosesso VN, Link MS, Maron BJ. Inter-association Task Force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement. J Athl Train. 2007 Jan-Mar; 42(1):143-58.
    View in: PubMed
    Score: 0.017
  124. Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006 Nov 21; 114(21):2232-9.
    View in: PubMed
    Score: 0.016
  125. Adabag AS, Kuskowski MA, Maron BJ. Determinants for clinical diagnosis of hypertrophic cardiomyopathy. Am J Cardiol. 2006 Dec 01; 98(11):1507-11.
    View in: PubMed
    Score: 0.016
  126. Harris KM, Sponsel A, Hutter AM, Maron BJ. Brief communication: Cardiovascular screening practices of major North American professional sports teams. Ann Intern Med. 2006 Oct 03; 145(7):507-11.
    View in: PubMed
    Score: 0.016
  127. Pelliccia A, Di Paolo FM, Corrado D, Buccolieri C, Quattrini FM, Pisicchio C, Spataro A, Biffi A, Granata M, Maron BJ. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. Eur Heart J. 2006 Sep; 27(18):2196-200.
    View in: PubMed
    Score: 0.016
  128. Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, Mackey-Bojack S, Manning WJ, Udelson JE, Maron BJ. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation. 2006 Jul 18; 114(3):216-25.
    View in: PubMed
    Score: 0.016
  129. Roberts WO, Maron BJ. Evidence for decreasing occurrence of sudden cardiac death associated with the marathon. J Am Coll Cardiol. 2005 Oct 04; 46(7):1373-4.
    View in: PubMed
    Score: 0.015
  130. Maron BJ, Wentzel DC, Zenovich AG, Estes NA, Link MS. Death in a young athlete due to commotio cordis despite prompt external defibrillation. Heart Rhythm. 2005 Sep; 2(9):991-3.
    View in: PubMed
    Score: 0.015
  131. Rickers C, Wilke NM, Jerosch-Herold M, Casey SA, Panse P, Panse N, Weil J, Zenovich AG, Maron BJ. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation. 2005 Aug 09; 112(6):855-61.
    View in: PubMed
    Score: 0.015
  132. Olivotto I, Maron MS, Adabag AS, Casey SA, Vargiu D, Link MS, Udelson JE, Cecchi F, Maron BJ. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005 Aug 02; 46(3):480-7.
    View in: PubMed
    Score: 0.015
  133. Almquist AK, Montgomery JV, Haas TS, Maron BJ. Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy. Heart Rhythm. 2005 Aug; 2(8):814-9.
    View in: PubMed
    Score: 0.015
  134. Montgomery JV, Harris KM, Casey SA, Zenovich AG, Maron BJ. Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. Am J Cardiol. 2005 Jul 15; 96(2):270-5.
    View in: PubMed
    Score: 0.015
  135. Gornick CC, Hauser RG, Almquist AK, Maron BJ. Unpredictable implantable cardioverter-defibrillator pulse generator failure due to electrical overstress causing sudden death in a young high-risk patient with hypertrophic cardiomyopathy. Heart Rhythm. 2005 Jul; 2(7):681-3.
    View in: PubMed
    Score: 0.015
  136. Maron MS, Zenovich AG, Casey SA, Link MS, Udelson JE, Aeppli DM, Maron BJ. Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy. Am J Cardiol. 2005 Jun 01; 95(11):1329-33.
    View in: PubMed
    Score: 0.015
  137. Sherrid MV, Barac I, McKenna WJ, Elliott PM, Dickie S, Chojnowska L, Casey S, Maron BJ. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005 Apr 19; 45(8):1251-8.
    View in: PubMed
    Score: 0.015
  138. Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005 Mar 01; 45(5):697-704.
    View in: PubMed
    Score: 0.015
  139. Fath AR, Aglan A, Maron MS, Phillips JS, Maron BJ, Rowin EJ. Cardiovascular outcomes of glucagon-like peptide-1 agonist in patients with obesity and hypertrophic cardiomyopathy. Int J Cardiol. 2025 May 01; 426:133082.
    View in: PubMed
    Score: 0.015
  140. Massera D, Sherrid MV, Adlestein E, Bokhari N, Alvarez IC, Wu WY, Reuter MC, Maron MS, Maron BJ, Rowin EJ. Disopyramide Revisited for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy: Efficacy and Safety in Patients Treated for at Least 5?Years. J Am Heart Assoc. 2025 Jan 21; 14(2):e037639.
    View in: PubMed
    Score: 0.014
  141. Zenovich AG, Lesser JR, Casey SA, Maron BJ. Images in cardiovascular medicine. Hypertrophic cardiomyopathy with apical aneurysm. Circulation. 2004 Oct 19; 110(16):e450.
    View in: PubMed
    Score: 0.014
  142. Maron BJ, Spirito P, Roman MJ, Paranicas M, Okin PM, Best LG, Lee ET, Devereux RB. Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study). Am J Cardiol. 2004 Jun 15; 93(12):1510-4.
    View in: PubMed
    Score: 0.014
  143. Aglan A, Fath AR, Maron BJ, Maron MS, Prasad A, Almomani A, Hammadah M, Reynolds MR, Rowin EJ. Percutaneous left atrial appendage closure for stroke prevention in hypertrophic cardiomyopathy patients with atrial fibrillation. Heart Rhythm. 2024 09; 21(9):1677-1683.
    View in: PubMed
    Score: 0.014
  144. Bonaventura J, Rowin EJ, Chan RH, Chin MT, Puchnerova V, Polakova E, Macek M, Votypka P, Batorsky R, Perera G, Koethe B, Veselka J, Maron BJ, Maron MS. Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy. J Am Heart Assoc. 2024 May 21; 13(10):e033565.
    View in: PubMed
    Score: 0.014
  145. Maron BJ, Tholakanahalli VN, Zenovich AG, Casey SA, Duprez D, Aeppli DM, Cohn JN. Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy. Circulation. 2004 Mar 02; 109(8):984-9.
    View in: PubMed
    Score: 0.014
  146. Maron BJ, Barry JA, Poole RS. Pilots, hypertrophic cardiomyopathy, and issues of aviation and public safety. Am J Cardiol. 2004 Feb 15; 93(4):441-4.
    View in: PubMed
    Score: 0.014
  147. Sarto P, Merlo L, Noventa D, Basso C, Pelliccia A, Maron BJ. Electrocardiographic changes associated with training and discontinuation of training in an athlete with hypertrophic cardiomyopathy. Am J Cardiol. 2004 Feb 15; 93(4):518-9.
    View in: PubMed
    Score: 0.014
  148. Kimmelstiel CD, Maron BJ. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Circulation. 2004 Feb 03; 109(4):452-6.
    View in: PubMed
    Score: 0.014
  149. Carrick RT, Ahamed H, Sung E, Maron MS, Madias C, Avula V, Studley R, Bao C, Bokhari N, Quintana E, Rajesh-Kannan R, Maron BJ, Wu KC, Rowin EJ. Identification of high-risk imaging features in hypertrophic cardiomyopathy using electrocardiography: A deep-learning approach. Heart Rhythm. 2024 08; 21(8):1390-1397.
    View in: PubMed
    Score: 0.013
  150. Kitaoka H, Doi Y, Casey SA, Hitomi N, Furuno T, Maron BJ. Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. Am J Cardiol. 2003 Nov 15; 92(10):1183-6.
    View in: PubMed
    Score: 0.013
  151. Maron BJ, Casey SA, Hauser RG, Aeppli DM. Clinical course of hypertrophic cardiomyopathy with survival to advanced age. J Am Coll Cardiol. 2003 Sep 03; 42(5):882-8.
    View in: PubMed
    Score: 0.013
  152. Maron BJ, Poliac LC, Ashare AB, Hall WA. Sudden death due to neck blows among amateur hockey players. JAMA. 2003 Aug 06; 290(5):599-601.
    View in: PubMed
    Score: 0.013
  153. Maron BJ, Estes NA, Maron MS, Almquist AK, Link MS, Udelson JE. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. Circulation. 2003 Jun 17; 107(23):2872-5.
    View in: PubMed
    Score: 0.013
  154. Maron BJ, Casey SA, Hurrell DG, Aeppli DM. Relation of left ventricular thickness to age and gender in hypertrophic cardiomyopathy. Am J Cardiol. 2003 May 15; 91(10):1195-8.
    View in: PubMed
    Score: 0.013
  155. Nistri S, Thiene G, Basso C, Corrado D, Vitolo A, Maron BJ. Screening for hypertrophic cardiomyopathy in a young male military population. Am J Cardiol. 2003 Apr 15; 91(8):1021-3, A8.
    View in: PubMed
    Score: 0.013
  156. Maron BJ, Carney KP, Lever HM, Lewis JF, Barac I, Casey SA, Sherrid MV. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003 Mar 19; 41(6):974-80.
    View in: PubMed
    Score: 0.013
  157. Maron BJ, Piccininno M, Casey SA, Bernab? P, Spirito P. Relation of extreme left ventricular hypertrophy to age in hypertrophic cardiomyopathy. Am J Cardiol. 2003 Mar 01; 91(5):626-8.
    View in: PubMed
    Score: 0.013
  158. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003 Jan 23; 348(4):295-303.
    View in: PubMed
    Score: 0.013
  159. Maron BJ. Cardiology patient pages. Hypertrophic cardiomyopathy. Circulation. 2002 Nov 05; 106(19):2419-21.
    View in: PubMed
    Score: 0.012
  160. Strasburger JF, Maron BJ. Images in clinical medicine. Commotio cordis. N Engl J Med. 2002 Oct 17; 347(16):1248.
    View in: PubMed
    Score: 0.012
  161. Ratliff NB, Harris KM, Smith SA, Tankh-Johnson M, Gornick CC, Maron BJ. Cardiac arrest in a young marathon runner. Lancet. 2002 Aug 17; 360(9332):542.
    View in: PubMed
    Score: 0.012
  162. Biffi A, Pelliccia A, Verdile L, Fernando F, Spataro A, Caselli S, Santini M, Maron BJ. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol. 2002 Aug 07; 40(3):446-52.
    View in: PubMed
    Score: 0.012
  163. Maron BJ, Casey SA, Almquist AK. Images in cardiovascular medicine. Hypertrophic cardiomyopathy in monozygotic twins. Circulation. 2002 May 07; 105(18):2229.
    View in: PubMed
    Score: 0.012
  164. Maron BJ, Sharkey SW, Casey SA, Lawler CM. Two husbands--one disease: the broad clinical spectrum of hypertrophic cardiomyopathy. Am J Cardiol. 2002 Apr 01; 89(7):899-900.
    View in: PubMed
    Score: 0.012
  165. Maron BJ, Gohman TE, Kyle SB, Estes NA, Link MS. Clinical profile and spectrum of commotio cordis. JAMA. 2002 Mar 06; 287(9):1142-6.
    View in: PubMed
    Score: 0.012
  166. Maron BJ, Olivotto I, Bellone P, Conte MR, Cecchi F, Flygenring BP, Casey SA, Gohman TE, Bongioanni S, Spirito P. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002 Jan 16; 39(2):301-7.
    View in: PubMed
    Score: 0.012
  167. Maron BJ, Mitten MJ, Greene Burnett C. Criminal consequences of commotio cordis. Am J Cardiol. 2002 Jan 15; 89(2):210-3.
    View in: PubMed
    Score: 0.012
  168. Sridharan A, Maron MS, Carrick RT, Madias CA, Huang D, Cooper C, Drummond J, Maron BJ, Rowin EJ. Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2022 01; 33(1):20-29.
    View in: PubMed
    Score: 0.012
  169. Maron MS, Rastegar H, Dolan N, Carpino P, Koethe B, Maron BJ, Rowin EJ. Outcomes Over Follow-up =10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy. Am J Cardiol. 2022 01 15; 163:91-97.
    View in: PubMed
    Score: 0.012
  170. Alcalai R, Arad M, Wakimoto H, Yadin D, Gorham J, Wang L, Burns E, Maron BJ, Roberts WC, Konno T, Conner DA, Perez-Atayde AR, Seidman JG, Seidman CE. LAMP2 Cardiomyopathy: Consequences of Impaired Autophagy in the Heart. J Am Heart Assoc. 2021 09 07; 10(17):e018829.
    View in: PubMed
    Score: 0.011
  171. Rowin EJ, Maron BJ, Wells S, Burrows A, Firely C, Koethe B, Patel AR, Maron MS. Usefulness of Global Longitudinal Strain to Predict Heart Failure Progression in Patients With Nonobstructive Hypertrophic Cardiomyopathy. Am J Cardiol. 2021 07 15; 151:86-92.
    View in: PubMed
    Score: 0.011
  172. Carrick RT, Maron MS, Adler A, Wessler B, Hoss S, Chan RH, Sridharan A, Huang D, Cooper C, Drummond J, Rakowski H, Maron BJ, Rowin EJ. Development and Validation of a Clinical Predictive Model for Identifying Hypertrophic Cardiomyopathy Patients at Risk for Atrial Fibrillation: The HCM-AF Score. Circ Arrhythm Electrophysiol. 2021 06; 14(6):e009796.
    View in: PubMed
    Score: 0.011
  173. Rowin EJ, Maron BJ, Carrick RT, Patel PP, Koethe B, Wells S, Maron MS. Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction. J Am Coll Cardiol. 2020 06 23; 75(24):3033-3043.
    View in: PubMed
    Score: 0.011
  174. Adalsteinsdottir B, Burke M, Maron BJ, Danielsen R, Lopez B, Diez J, Jarolim P, Seidman J, Seidman CE, Ho CY, Gunnarsson GT. Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers. Open Heart. 2020; 7(1):e001220.
    View in: PubMed
    Score: 0.010
  175. Kumar KR, Mandleywala SN, Madias C, Weinstock J, Rowin EJ, Maron BJ, Maron MS, Link MS. Single Coil Implantable Cardioverter Defibrillator Leads in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2020 06 15; 125(12):1896-1900.
    View in: PubMed
    Score: 0.010
  176. Sherrid MV, Riedy K, Rosenzweig B, Massera D, Saric M, Swistel DG, Ahluwalia M, Arabadjian M, DeFonte M, Stepanovic A, Serrato S, Xia Y, Zhong H, Maron MS, Maron BJ, Reynolds HR. Distinctive Hypertrophic Cardiomyopathy Anatomy and Obstructive Physiology in Patients Admitted With Takotsubo Syndrome. Am J Cardiol. 2020 06 01; 125(11):1700-1709.
    View in: PubMed
    Score: 0.010
  177. Boll G, Rowin EJ, Maron BJ, Wang W, Rastegar H, Maron MS. Efficacy of Combined Cox-Maze IV and Ventricular Septal Myectomy for Treatment of Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy. Am J Cardiol. 2020 01 01; 125(1):120-126.
    View in: PubMed
    Score: 0.010
  178. Kimmelstiel C, Zisa DC, Kuttab JS, Wells S, Udelson JE, Wessler BS, Rastegar H, Kapur NK, Weintraub AR, Maron BJ, Maron MS, Rowin EJ. Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes. Circ Cardiovasc Interv. 2019 07; 12(7):e007673.
    View in: PubMed
    Score: 0.010
  179. Thiene G, Rizzo S, Schiavon M, Maron MS, Zorzi A, Corrado D, Maron BJ, Basso C. Structurally Normal Hearts Are Uncommonly Associated With Sudden Deaths in Athletes and Young People. J Am Coll Cardiol. 2019 06 18; 73(23):3031-3032.
    View in: PubMed
    Score: 0.010
  180. Cooper S, Woodford NW, Maron BJ, Harris KM, Sheppard MN. A Lethal Blow to the Chest as an Underdiagnosed Cause of Sudden Death in United Kingdom Sports (Football, Cricket, Rugby). Am J Cardiol. 2019 09 01; 124(5):808-811.
    View in: PubMed
    Score: 0.010
  181. Rowin EJ, Romashko M, Testani JM, Koethe BC, Saxena D, Udelson JE, Maron BJ, Maron MS. Chronic Heart Failure Is Infrequently Associated With Renal Dysfunction in Hypertrophic Cardiomyopathy. J Card Fail. 2019 08; 25(8):690-692.
    View in: PubMed
    Score: 0.010
  182. Rowin EJ, Maron BJ, Romashko M, Wang W, Rastegar H, Link MS, Maron MS. Impact of Effective Management Strategies on Patients With the Most Extreme Phenotypic Expression of Hypertrophic Cardiomyopathy. Am J Cardiol. 2019 07 01; 124(1):113-121.
    View in: PubMed
    Score: 0.010
  183. Miller CAS, Maron MS, Estes NAM, Price LL, Rowin EJ, Maron BJ, Link MS. Safety, Side Effects and Relative Efficacy of Medications for Rhythm Control of Atrial Fibrillation in Hypertrophic Cardiomyopathy. Am J Cardiol. 2019 06 01; 123(11):1859-1862.
    View in: PubMed
    Score: 0.010
  184. Madias C, Maron BJ, Dau N, Estes NAM, Bir C, Link MS. Size as an Important Determinant of Chest Blow-induced Commotio Cordis. Med Sci Sports Exerc. 2018 09; 50(9):1767-1771.
    View in: PubMed
    Score: 0.009
  185. Rowin EJ, Maron BJ, Chokshi A, Kannappan M, Arkun K, Wang W, Rastegar H, Maron MS. Clinical Spectrum and Management Implications of Left Ventricular Outflow Obstruction With Mild Ventricular Septal Thickness in Hypertrophic Cardiomyopathy. Am J Cardiol. 2018 10 15; 122(8):1409-1420.
    View in: PubMed
    Score: 0.009
  186. Maron MS, Chan RH, Kapur NK, Jaffe IZ, McGraw AP, Kerur R, Maron BJ, Udelson JE. Effect of Spironolactone on Myocardial Fibrosis and Other Clinical Variables in Patients with Hypertrophic Cardiomyopathy. Am J Med. 2018 07; 131(7):837-841.
    View in: PubMed
    Score: 0.009
  187. Rowin EJ, Maron BJ, Abt P, Kiernan MS, Vest A, Costantino F, Maron MS, DeNofrio D. Impact of Advanced Therapies for Improving Survival to Heart Transplant in Patients with Hypertrophic Cardiomyopathy. Am J Cardiol. 2018 04 15; 121(8):986-996.
    View in: PubMed
    Score: 0.009
  188. Rowin EJ, Maron BJ, Olivotto I, Maron MS. Role of Exercise Testing in Hypertrophic?Cardiomyopathy. JACC Cardiovasc Imaging. 2017 11; 10(11):1374-1386.
    View in: PubMed
    Score: 0.009
  189. Rowin EJ, Maron BJ, Arkun K, Maron MS. Anatomic validation of late gadolinium enhancement as evidence of myocardial scarring in LAMP2 cardiomyopathy. Eur Heart J. 2017 08 14; 38(31):2444.
    View in: PubMed
    Score: 0.009
  190. Adalsteinsdottir B, Palsson R, Desnick RJ, Gardarsdottir M, Teekakirikul P, Maron M, Appelbaum E, Neisius U, Maron BJ, Burke MA, Chen B, Pagant S, Madsen CV, Danielsen R, Arngrimsson R, Feldt-Rasmussen U, Seidman JG, Seidman CE, Gunnarsson GT. Fabry Disease in Families With Hypertrophic Cardiomyopathy: Clinical Manifestations in the Classic and Later-Onset Phenotypes. Circ Cardiovasc Genet. 2017 Aug; 10(4).
    View in: PubMed
    Score: 0.009
  191. Kannappan M, Maron BJ, Rastegar H, Pandian NG, Maron MS, Rowin EJ. Underappreciated occurrence of discrete subaortic membranes producing left ventricular outflow obstruction in hypertrophic cardiomyopathy. Echocardiography. 2017 Aug; 34(8):1247-1249.
    View in: PubMed
    Score: 0.009
  192. Lampert R, Olshansky B, Heidbuchel H, Lawless C, Saarel E, Ackerman M, Calkins H, Estes NAM, Link MS, Maron BJ, Marcus F, Scheinman M, Wilkoff BL, Zipes DP, Berul CI, Cheng A, Jordaens L, Law I, Loomis M, Willems R, Barth C, Broos K, Brandt C, Dziura J, Li F, Simone L, Vandenberghe K, Cannom D. Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Long-Term Results of a Prospective Multinational Registry. Circulation. 2017 06 06; 135(23):2310-2312.
    View in: PubMed
    Score: 0.009
  193. Covella M, Rowin EJ, Hill NS, Preston IR, Milan A, Opotowsky AR, Maron BJ, Maron MS, Maron BA. Mechanism of Progressive Heart Failure and Significance of Pulmonary Hypertension in Obstructive Hypertrophic Cardiomyopathy. Circ Heart Fail. 2017 Apr; 10(4):e003689.
    View in: PubMed
    Score: 0.008
  194. Wang W, Lian Z, Rowin EJ, Maron BJ, Maron MS, Link MS. Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy. Circ Arrhythm Electrophysiol. 2017 Mar; 10(3).
    View in: PubMed
    Score: 0.008
  195. Rowin EJ, Maron BJ, Haas TS, Garberich RF, Wang W, Link MS, Maron MS. Hypertrophic Cardiomyopathy With Left?Ventricular Apical Aneurysm: Implications for Risk Stratification and Management. J Am Coll Cardiol. 2017 02 21; 69(7):761-773.
    View in: PubMed
    Score: 0.008
  196. Weissler-Snir A, Hindieh W, Gruner C, Fourey D, Appelbaum E, Rowin E, Care M, Lesser JR, Haas TS, Udelson JE, Manning WJ, Olivotto I, Tomberli B, Maron BJ, Maron MS, Crean AM, Rakowski H, Chan RH. Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (?-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy. Circ Cardiovasc Imaging. 2017 Feb; 10(2).
    View in: PubMed
    Score: 0.008
  197. Konstantinou DM, Efthimiadis GK, Vassilikos V, Paraskevaidis S, Pagourelias E, Maron BJ, Karvounis H. Implantable cardioverter defibrillators for primary prevention of sudden death in hypertrophic cardiomyopathy. J Cardiovasc Med (Hagerstown). 2016 Jun; 17(6):433-9.
    View in: PubMed
    Score: 0.008
  198. Lynge TH, Risgaard B, Jabbari R, Glinge C, Bundgaard H, Maron B, Hauns? S, Winkel BG, Tfelt-Hansen J. Cardiac symptoms before sudden cardiac death caused by hypertrophic cardiomyopathy: a nationwide study among the young in Denmark. Europace. 2016 Dec; 18(12):1801-1808.
    View in: PubMed
    Score: 0.008
  199. Williams LK, Chan RH, Carasso S, Durand M, Misurka J, Crean AM, Ralph-Edwards A, Gruner C, Woo A, Lesser JR, Maron BJ, Maron MS, Rakowski H. Effect of Left Ventricular Outflow Tract Obstruction on Left Atrial Mechanics in Hypertrophic Cardiomyopathy. Biomed Res Int. 2015; 2015:481245.
    View in: PubMed
    Score: 0.008
  200. Mitten MJ, Zipes DP, Maron BJ, Bryant WJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2447-2450.
    View in: PubMed
    Score: 0.008
  201. Ferrazzi P, Spirito P, Iacovoni A, Calabrese A, Migliorati K, Simon C, Pentiricci S, Poggio D, Grillo M, Amigoni P, Iascone M, Mortara A, Maron BJ, Senni M, Bruzzi P. Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy. J Am Coll Cardiol. 2015 Oct 13; 66(15):1687-96.
    View in: PubMed
    Score: 0.008
  202. Chan RH, Maron BJ, Olivotto I, Assenza GE, Haas TS, Lesser JR, Gruner C, Crean AM, Rakowski H, Rowin E, Udelson J, Lombardi M, Tomberli B, Spirito P, Formisano F, Marra MP, Biagini E, Autore C, Manning WJ, Appelbaum E, Roberts WC, Basso C, Maron MS. Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2015 Aug 01; 116(3):436-41.
    View in: PubMed
    Score: 0.007
  203. Rowin EJ, Maron BJ, Kiernan MS, Casey SA, Feldman DS, Hryniewicz KM, Chan RH, Harris KM, Udelson JE, DeNofrio D, Roberts WC, Maron MS. Advanced heart failure with preserved systolic function in nonobstructive hypertrophic cardiomyopathy: under-recognized subset of candidates for heart transplant. Circ Heart Fail. 2014 Nov; 7(6):967-75.
    View in: PubMed
    Score: 0.007
  204. Verdile L, Maron BJ, Pelliccia A, Spataro A, Santini M, Biffi A. Clinical significance of exercise-induced ventricular tachyarrhythmias in trained athletes without cardiovascular abnormalities. Heart Rhythm. 2015 Jan; 12(1):78-85.
    View in: PubMed
    Score: 0.007
  205. Caselli S, Maron MS, Urbano-Moral JA, Pandian NG, Maron BJ, Pelliccia A. Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2014 Nov 01; 114(9):1383-9.
    View in: PubMed
    Score: 0.007
  206. Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, Lesser JR, Gruner C, Crean AM, Rakowski H, Udelson JE, Rowin E, Lombardi M, Cecchi F, Tomberli B, Spirito P, Formisano F, Biagini E, Rapezzi C, De Cecco CN, Autore C, Cook EF, Hong SN, Gibson CM, Manning WJ, Appelbaum E, Maron MS. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 2014 Aug 05; 130(6):484-95.
    View in: PubMed
    Score: 0.007
  207. Adalsteinsdottir B, Teekakirikul P, Maron BJ, Burke MA, Gudbjartsson DF, Holm H, Stefansson K, DePalma SR, Mazaika E, McDonough B, Danielsen R, Seidman JG, Seidman CE, Gunnarsson GT. Nationwide study on hypertrophic cardiomyopathy in Iceland: evidence of a MYBPC3 founder mutation. Circulation. 2014 Sep 30; 130(14):1158-67.
    View in: PubMed
    Score: 0.007
  208. Biagini E, Olivotto I, Iascone M, Parodi MI, Girolami F, Frisso G, Autore C, Limongelli G, Cecconi M, Maron BJ, Maron MS, Rosmini S, Formisano F, Musumeci B, Cecchi F, Iacovoni A, Haas TS, Bacchi Reggiani ML, Ferrazzi P, Salvatore F, Spirito P, Rapezzi C. Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy. Am J Cardiol. 2014 Sep 01; 114(5):769-76.
    View in: PubMed
    Score: 0.007
  209. Gruner C, Chan RH, Crean A, Rakowski H, Rowin EJ, Care M, Deva D, Williams L, Appelbaum E, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Siminovitch K, Ralph-Edwards AC, Rastegar H, Maron BJ, Maron MS. Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Eur Heart J. 2014 Oct 14; 35(39):2706-13.
    View in: PubMed
    Score: 0.007
  210. Efthimiadis GK, Pitsis A, Pagourelias ED, Kamperidis V, Kelpis T, Meditskou S, Hadjimiltiades S, Ninios V, Mezilis N, Maron BJ, Styliadis IH. Surgical septal myectomy for hypertrophic cardiomyopathy in Greece: a single-center initial experience. Hellenic J Cardiol. 2014 Mar-Apr; 55(2):132-8.
    View in: PubMed
    Score: 0.007
  211. Lampert R, Olshansky B, Heidbuchel H, Lawless C, Saarel E, Ackerman M, Calkins H, Estes NA, Link MS, Maron BJ, Marcus F, Scheinman M, Wilkoff BL, Zipes DP, Berul CI, Cheng A, Law I, Loomis M, Barth C, Brandt C, Dziura J, Li F, Cannom D. Safety of sports for athletes with implantable cardioverter-defibrillators: results of a prospective, multinational registry. Circulation. 2013 May 21; 127(20):2021-30.
    View in: PubMed
    Score: 0.006
  212. Olivotto I, Maron BJ, Tomberli B, Appelbaum E, Salton C, Haas TS, Gibson CM, Nistri S, Servettini E, Chan RH, Udelson JE, Lesser JR, Cecchi F, Manning WJ, Maron MS. Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2013 Jul 30; 62(5):449-57.
    View in: PubMed
    Score: 0.006
  213. Rowin EJ, Maron BJ, Lesser JR, Rastegar H, Maron MS. Papillary muscle insertion directly into the anterior mitral leaflet in hypertrophic cardiomyopathy, its identification and cause of outflow obstruction by cardiac magnetic resonance imaging, and its surgical management. Am J Cardiol. 2013 Jun 01; 111(11):1677-9.
    View in: PubMed
    Score: 0.006
  214. Sharkey SW, Maron BJ, Lesser JR. Authors' reply: takotsubo cardiomyopathy. Am J Cardiol. 2013 Feb 15; 111(4):628.
    View in: PubMed
    Score: 0.006
  215. Rowin EJ, Maron BJ, Appelbaum E, Link MS, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron MS. Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy. Am J Cardiol. 2012 Oct 01; 110(7):1027-32.
    View in: PubMed
    Score: 0.006
  216. Appelbaum E, Maron BJ, Adabag S, Hauser TH, Lesser JR, Haas TS, Riley AB, Harrigan CJ, Delling FN, Udelson JE, Gibson CM, Manning WJ, Maron MS. Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. 2012 Jan; 5(1):78-85.
    View in: PubMed
    Score: 0.006
  217. Lakdawala NK, Thune JJ, Maron BJ, Cirino AL, Havndrup O, Bundgaard H, Christiansen M, Carlsen CM, Dorval JF, Kwong RY, Colan SD, K?ber LV, Ho CY. Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy. Am J Cardiol. 2011 Dec 01; 108(11):1606-13.
    View in: PubMed
    Score: 0.006
  218. Biffi A, Maron BJ, Culasso F, Verdile L, Fernando F, Di Giacinto B, Di Paolo FM, Spataro A, Delise P, Pelliccia A. Patterns of ventricular tachyarrhythmias associated with training, deconditioning and retraining in elite athletes without cardiovascular abnormalities. Am J Cardiol. 2011 Mar 01; 107(5):697-703.
    View in: PubMed
    Score: 0.006
  219. Bos JM, Maron BJ, Ackerman MJ, Haas TS, Sorajja P, Nishimura RA, Gersh BJ, Ommen SR. Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy. Am J Cardiol. 2010 Nov 15; 106(10):1481-6.
    View in: PubMed
    Score: 0.005
  220. Harrigan CJ, Peters DC, Gibson CM, Maron BJ, Manning WJ, Maron MS, Appelbaum E. Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging. Radiology. 2011 Jan; 258(1):128-33.
    View in: PubMed
    Score: 0.005
  221. Olivotto I, Maron BJ, Appelbaum E, Harrigan CJ, Salton C, Gibson CM, Udelson JE, O'Donnell C, Lesser JR, Manning WJ, Maron MS. Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Am J Cardiol. 2010 Jul 15; 106(2):261-7.
    View in: PubMed
    Score: 0.005
  222. Maron MS, Olivotto I, Maron BJ, Prasad SK, Cecchi F, Udelson JE, Camici PG. The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2009 Aug 25; 54(9):866-75.
    View in: PubMed
    Score: 0.005
  223. Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I, Biller L, Lesser JR, Udelson JE, Manning WJ, Appelbaum E. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol. 2009 Jul 14; 54(3):220-8.
    View in: PubMed
    Score: 0.005
  224. Madias C, Maron BJ, Alsheikh-Ali AA, Rajab M, Estes NA, Link MS. Precordial thump for cardiac arrest is effective for asystole but not for ventricular fibrillation. Heart Rhythm. 2009 Oct; 6(10):1495-500.
    View in: PubMed
    Score: 0.005
  225. Ho CY, Carlsen C, Thune JJ, Havndrup O, Bundgaard H, Farrohi F, Rivero J, Cirino AL, Andersen PS, Christiansen M, Maron BJ, Orav EJ, K?ber L. Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy. Circ Cardiovasc Genet. 2009 Aug; 2(4):314-21.
    View in: PubMed
    Score: 0.005
  226. Lim KK, Maron BJ, Knight BP. Successful catheter ablation of hemodynamically unstable monomorphic ventricular tachycardia in a patient with hypertrophic cardiomyopathy and apical aneurysm. J Cardiovasc Electrophysiol. 2009 Apr; 20(4):445-7.
    View in: PubMed
    Score: 0.005
  227. Hauser RG, Maron BJ, Marine JE, Lampert R, Kadish AH, Winters SL, Scher DL, Biria M, Kalia A. Safety and efficacy of transvenous high-voltage implantable cardioverter-defibrillator leads in high-risk hypertrophic cardiomyopathy patients. Heart Rhythm. 2008 Nov; 5(11):1517-22.
    View in: PubMed
    Score: 0.005
  228. Madias C, Maron BJ, Supron S, Estes NA, Link MS. Cell membrane stretch and chest blow-induced ventricular fibrillation: commotio cordis. J Cardiovasc Electrophysiol. 2008 Dec; 19(12):1304-9.
    View in: PubMed
    Score: 0.005
  229. Magalski A, Maron BJ, Main ML, McCoy M, Florez A, Reid KJ, Epps HW, Bates J, Browne JE. Relation of race to electrocardiographic patterns in elite American football players. J Am Coll Cardiol. 2008 Jun 10; 51(23):2250-5.
    View in: PubMed
    Score: 0.005
  230. Biffi A, Maron BJ, Di Giacinto B, Porcacchia P, Verdile L, Fernando F, Spataro A, Culasso F, Casasco M, Pelliccia A. Relation between training-induced left ventricular hypertrophy and risk for ventricular tachyarrhythmias in elite athletes. Am J Cardiol. 2008 Jun 15; 101(12):1792-5.
    View in: PubMed
    Score: 0.005
  231. Adabag AS, Maron BJ, Appelbaum E, Harrigan CJ, Buros JL, Gibson CM, Lesser JR, Hanna CA, Udelson JE, Manning WJ, Maron MS. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol. 2008 Apr 08; 51(14):1369-74.
    View in: PubMed
    Score: 0.005
  232. Harrigan CJ, Appelbaum E, Maron BJ, Buros JL, Gibson CM, Lesser JR, Udelson JE, Manning WJ, Maron MS. Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Am J Cardiol. 2008 Mar 01; 101(5):668-73.
    View in: PubMed
    Score: 0.004
  233. Cha YM, Gersh BJ, Maron BJ, Boriani G, Spirito P, Hodge DO, Weivoda PL, Trusty JM, Friedman PA, Hammill SC, Rea RF, Shen WK. Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2007 May; 18(5):483-7.
    View in: PubMed
    Score: 0.004
  234. Nistri S, Olivotto I, Betocchi S, Losi MA, Valsecchi G, Pinamonti B, Conte MR, Casazza F, Galderisi M, Maron BJ, Cecchi F. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). Am J Cardiol. 2006 Oct 01; 98(7):960-5.
    View in: PubMed
    Score: 0.004
  235. Salib EA, Cyran SE, Cilley RE, Maron BJ, Thomas NJ. Efficacy of bystander cardiopulmonary resuscitation and out-of-hospital automated external defibrillation as life-saving therapy in commotio cordis. J Pediatr. 2005 Dec; 147(6):863-6.
    View in: PubMed
    Score: 0.004
  236. Arad M, Penas-Lado M, Monserrat L, Maron BJ, Sherrid M, Ho CY, Barr S, Karim A, Olson TM, Kamisago M, Seidman JG, Seidman CE. Gene mutations in apical hypertrophic cardiomyopathy. Circulation. 2005 Nov 01; 112(18):2805-11.
    View in: PubMed
    Score: 0.004
  237. Pelliccia A, Maron BJ, Di Paolo FM, Biffi A, Quattrini FM, Pisicchio C, Roselli A, Caselli S, Culasso F. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol. 2005 Aug 16; 46(4):690-6.
    View in: PubMed
    Score: 0.004
  238. Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, Gersh BJ, Ackerman MJ, McCully RB, Dearani JA, Schaff HV, Danielson GK, Tajik AJ, Nishimura RA. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005 Aug 02; 46(3):470-6.
    View in: PubMed
    Score: 0.004
  239. Garan AR, Maron BJ, Wang PJ, Estes NA, Link MS. Role of streptomycin-sensitive stretch-activated channel in chest wall impact induced sudden death (commotio cordis). J Cardiovasc Electrophysiol. 2005 Apr; 16(4):433-8.
    View in: PubMed
    Score: 0.004
  240. Arad M, Maron BJ, Gorham JM, Johnson WH, Saul JP, Perez-Atayde AR, Spirito P, Wright GB, Kanter RJ, Seidman CE, Seidman JG. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med. 2005 Jan 27; 352(4):362-72.
    View in: PubMed
    Score: 0.004
  241. Boriani G, Maron BJ, Shen WK, Spirito P. Prevention of sudden death in hypertrophic cardiomyopathy: but which defibrillator for which patient? Circulation. 2004 Oct 12; 110(15):e438-42.
    View in: PubMed
    Score: 0.004
  242. Biffi A, Maron BJ, Verdile L, Fernando F, Spataro A, Marcello G, Ciardo R, Ammirati F, Colivicchi F, Pelliccia A. Impact of physical deconditioning on ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol. 2004 Sep 01; 44(5):1053-8.
    View in: PubMed
    Score: 0.004
  243. Basso C, Fox PR, Meurs KM, Towbin JA, Spier AW, Calabrese F, Maron BJ, Thiene G. Arrhythmogenic right ventricular cardiomyopathy causing sudden cardiac death in boxer dogs: a new animal model of human disease. Circulation. 2004 Mar 09; 109(9):1180-5.
    View in: PubMed
    Score: 0.003
  244. Minakata K, Dearani JA, Nishimura RA, Maron BJ, Danielson GK. Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae. J Thorac Cardiovasc Surg. 2004 Feb; 127(2):481-9.
    View in: PubMed
    Score: 0.003
  245. Sharma S, Maron BJ, Whyte G, Firoozi S, Elliott PM, McKenna WJ. Physiologic limits of left ventricular hypertrophy in elite junior athletes: relevance to differential diagnosis of athlete's heart and hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002 Oct 16; 40(8):1431-6.
    View in: PubMed
    Score: 0.003
  246. Ho CY, Sweitzer NK, McDonough B, Maron BJ, Casey SA, Seidman JG, Seidman CE, Solomon SD. Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation. 2002 Jun 25; 105(25):2992-7.
    View in: PubMed
    Score: 0.003
  247. Pelliccia A, Maron BJ, De Luca R, Di Paolo FM, Spataro A, Culasso F. Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning. Circulation. 2002 Feb 26; 105(8):944-9.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.